CCCC vs DD · rev $35.6M vs P/E 127, rev $12.39B
C4 Therapeutics Inc (CCCC) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
CCCC currently screens at market cap $425.7M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the CCCC and DD stock pages for the full models.
Not investment advice.